AVXL
AVXL clinical trials: ANAVEX LIFE SCIENCES CORP.
Every trial on ClinicalTrials.gov where ANAVEX LIFE SCIENCES CORP. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 13
- Trials linked
- 11
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
AVXL on the catalyst calendar · AVXL registry changes
- Primary completion Jun 30, 2025Sponsor estimatePhase 2NCT06245213A Study of ANAVEX3-71 in Adults With SchizophreniaAnavex Life Sciences Corp. · SchizophreniaActive, not recruitingAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 14, 2024ActualPhase 2/Phase 3NCT04314934OLE of Phase 2b/3 Study ANAVEX2-73-AD-004Anavex Life Sciences Corp. · Alzheimer DiseaseCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2023ActualPhase 2/Phase 3NCT04304482ANAVEX2-73 Study in Pediatric Patients With Rett SyndromeAnavex Life Sciences Corp. · Rett SyndromeCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2022ActualPhase 2NCT04575259OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001Anavex Life Sciences Corp. · Parkinson Disease DementiaCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2022ActualPhase 2/Phase 3NCT03790709ANAVEX2-73 for Treatment of Early Alzheimer's DiseaseAnavex Life Sciences Corp. · Alzheimer DiseaseCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2021ActualPhase 3NCT03941444ANAVEX2-73 Study in Patients With Rett SyndromeAnavex Life Sciences Corp. · Rett SyndromeCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2021ActualPhase 1NCT04442945Phase 1 Study of ANAVEX3-71Anavex Life Sciences Corp. · HealthyCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 30, 2020ActualPhase 2NCT03758924Study of ANAVEX2-73 in Patients With Rett SyndromeAnavex Life Sciences Corp. · Rett SyndromeCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2020ActualPhase 2NCT02756858An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's DiseaseAnavex Life Sciences Corp. · Alzheimer's DiseaseCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2020ActualPhase 2NCT03774459ANAVEX2-73 Study in Parkinson's Disease DementiaAnavex Life Sciences Corp. · Parkinsons Disease With DementiaCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2015ActualPhase 2NCT02244541Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's DiseaseAnavex Life Sciences Corp. · Alzheimer's DiseaseCompletedAVXLLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 12, 2022ActualEarly Phase 1NCT04928703Effects of Ketamine on ERP/EEG Measures in Healthy VolunteersERP Biomarker Qualification Consortium · Healthy
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 29, 2020ActualNo phase registeredNCT04025502Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer SubjectsERP Biomarker Qualification Consortium · Schizophrenia
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 13 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner